The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue derived products for advanced wound care, today ...
POMPANO BEACH, Fla. - BioStem Technologies, Inc. (OTC:BSEM), a microcap company with a market capitalization of $90.22 million, highlighted recent statements from FDA leadership indicating greater ...
In the first instalment of LCGC International's interview series exploring how artificial intelligence (AI)/machine learning ...
Primetimer on MSN
New analysis narrows possible sources of the Amaterasu cosmic ray
New analysis by Francesca Capel and Nadine Bourriche narrows possible sources of the Amaterasu cosmic ray, suggesting nearby galaxies like M82 rather than the Local Void.
Real-world data (RWD) is transforming clinical research, augmenting existing randomized controlled trial (RCT) data to de-risk studies and improve generalizability. With regulators setting clearer ...
Discover actuarial reserving in P&C insurance—from methods to innovations—enhancing stability and strategy. ✓ Subscribe for ...
LOUISVILLE, Ky., Feb. 3, 2026 /PRNewswire/ -- Cognision today unveiled Cognision360™, a groundbreaking web-based platform that consolidates multiple neurobiomarker data streams into a single, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results